SPECIAL NOTICE
66 -- Intent to Sole Source - College of American Pathologists
- Notice Date
- 2/8/2024 9:58:02 AM
- Notice Type
- Special Notice
- NAICS
- 621511
— Medical Laboratories
- Contracting Office
- 249-NETWORK CONTRACT OFFICE 9 (36C249) MURFREESBORO TN 37129 USA
- ZIP Code
- 37129
- Solicitation Number
- 36C24924Q0162
- Response Due
- 2/21/2024 8:00:00 AM
- Archive Date
- 04/21/2024
- Point of Contact
- Larry Olive, Contract Specialist, Phone: 615-225-2475
- E-Mail Address
-
larry.olive@va.gov
(larry.olive@va.gov)
- Awardee
- null
- Description
- Special Notice Special Notice Page 5 of 5 Special Notice DESCRIPTION *= Required Field Special Notice Page 1 of 5 Intent to Sole Source - The College of American Pathologists (CAP) SPECIAL NOTICE: 36C24924Q0162 The Department of Veterans Affairs intends to issue a sole-source firm-fixed priced contract to The College of American Pathologists (CAP) Calibration Verification/Linearity Program, 325 Waukegan Rd, Northfield, IL 60093-2719. In accordance with Federal Acquisition Regulation (FAR) 13.106-1(b)(1)(i) and on behalf of the Memphis Veterans Affairs Medical Center (VAMC), Clinical Laboratory, Network Contracting Office (NCO) 9 intends to issue an open market sole source firm-fixed priced contract to The College of American Pathologists (CAP) located at 325 Waukegan Rd, Northfield, IL 60093-2719. The rationale basis for the sole source acquisition is that CAP (Large Business) is the only Clinical Laboratory Improvement Amendments (CLIA) and Food and Drug Administration (FDA) approved responsible source that can provide the original equipment manufacturer (OEM) for the Calibration Verification/Linearity Instrumentation Programs that meets the linearity testing guidelines established to ensure compliant with CLIA federal guidelines and to ensure the Lab s testing procedures are consistent with established FDA, CLIA, and VHA regulations. CAP is the sole source manufacturer and distributor of CAP validation and linearity instrumentation materials currently being used by the Memphis Clinical Laboratory to satisfy their requirements for scheduled calibration verification and verification of the analytical measurement range as specified in the current CLIA licensing requirements and The Joint Commission (TJC) Laboratory accreditation requirements under 42 CFR 493.1255(bX3), as well to satisfy requirements to maintain their current CLIA accreditation. CAP sells directly to the end users facilities and as such, there are no agents or dealers authorized to represent this product. The North American Industry Classification System (NAICS) for this requirement is, 621511 - Product of Service Code for this requirement is 6640. The Small Business Administration (SBA) size standard for this sector is $41.5 M. Background. The Memphis VAMC, Clinical Laboratory, 116 North Pauline St., Memphis, TN 38105, has a requirement for CAP validation and linearity instrumentation materials. Delivery must be FOB destination 60 days after receipt of order. ITEM INFORMATION LINE-ITEM MFR PROGRAM CODE ITEM DESCRIPTION QTY EACH 0001 AQSQ QUALITY CROSS CHECK BLOOD GAS I-STAT 1 0002 BNPQ QUALITY CROSS CHECK-BNP 1 0003 CGLQ QUALITY CROSS CHECK-COAGULATION 1 0004 CMQ QUALITY CROSS CHEQUALITY CROSS CHECK-URINALYSIS 1 0005 CT5Q QUALITY CROSS CHECK-ACT 1 0006 CZQ QUALITY CROSS CHECK-CHEM/TDM 1 0007 FH9Q QUALITY CROSS CHECK-HEM 1 0008 HCRQ QCC-HIGH SENSITIVITY CARDIAC MARKERS 1 0009 ID3Q QCC-NAA, RESPIRATORY LIMITEDQCC-NAA, RESPIRATORY LIMITED 1 0010 PTHQ QUALITY CROSS CHECK-PARATHYROID HORMONE 1 0011 RT4Q QUALITY CROSS CHECK-RETICULOCYTE 1 0012 LN15 HEMOGLOBIN A1C ACCURACY CVL 1 0013 LN24 CREATININE ACCURACY CVL 2 0014 LN36 HEPARIN CVL 2 0015 LN42 D-DIMER CVLD 2 0016 LN44 FIBRINOGEN CVL 2 0017 LN2 CHEMISTRY/LIPID/ENZYME CVL 2 0018 LN3 THERAPEUTIC DRUG MONITORING CVL 2 0019 LN5 LIGAND ASSAY CVL 2 0020 LN6 URINE CHEMISTRY CVL 2 0021 LN8 REPRODUCTIVE ENDOCRINOLOGY CVL 1 0022 LN11 SERUM ETHANOL CVL 2 0023 LN12 C-REACTIVE PROTEIN CVL 1 0024 LN16 HOMOCYSTEINE CVL 1 0025 LN20 URINE ALBUMIN CVL 2 0026 LN23 PROSTATE-SPECIFIC ANTIGEN CVL 1 0027 LN25 TROPONIN I CVL 1 0028 LN30 B-TYPE NATRIURETIC PEPTIDE CVL 2 0029 LN32 AMMONIA CVL 2 0030 LN33 SERUM MYOGLOBIN CVL 2 0031 LN40 VITAMIN D CVL 2 0032 LN41 PROCALCITONIN CVL 1 0033 LN2BV CHEM CVL BECKMAN (EXCEPT AU), VITROS 3 0034 JATQ QUALITY CROSS CHECK-TRANSFUSION MEDICINE 1 0035 LN48 HIGH-SENSITIVITY TROPONIN I CVL 2 0036 CAPBIND CAP GENERIC SURVEY BINDER 5 0037 SOQ QUALITY CROSS CHECK-BLOOD OXIMETRY 1 Other important considerations: Cite any other information that is necessary for potential respondents to understand the nature of the potential requirement or proposed acquisition. Capability statement /information sought: Response to this announcement shall not to exceed 10 pages and should include the following information: (1) A tailored capability statement indicating the firm s ability to provide a product and related services; (2) The respondents DUNS number, organization name, address, point of contact, and size and type of business (e.g., SDVOSB/VOSB, etc,) pursuant to the applicable NAICS code; (3) Information should be provided electronically in a Microsoft Word or Adobe PDF format. This notice of intent is not a request for competitive quotes. However, interested parties may identify their interest and capability to respond to the requirement and submit capability statement no later than 10:00 am., CT, Wednesday, February 21, 2024, to: larry.olive@va.gov. Responses received will be evaluated; however, a determination by the Government not to compete the proposed procurement based upon responses received to this notice is solely within the discretion of the Government. If no written response is received within the closing date of this notice, a sole source award will be made to the College of American Pathologists (CAP) without any further notice. Disclaimer and Important Notes: This notice does not obligate the Government to award a contract or otherwise pay for the information provided in response to this notice. The Government reserves the right to use information provided by respondents for any purpose deemed necessary and legally appropriate. Any organization responding to this notice should ensure that its response is complete and sufficiently detailed to allow the Government to determine the organization's qualifications to perform the work. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted. However, responses to this notice will not be considered adequate responses to a notice.
- Web Link
-
SAM.gov Permalink
(https://sam.gov/opp/12332165593f45418a7550468813afa5/view)
- Record
- SN06959301-F 20240210/240208230047 (samdaily.us)
- Source
-
SAM.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's SAM Daily Index Page |